Phosphate Binders in CKD: ‟New Kids on the Block”

Авторы

  • Muhammad Umair Afzal
  • Shafeeq Cheema Jinah Hospital, Lahore

DOI:

https://doi.org/10.53778/pjkd31089

Ключевые слова:

hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxide

Аннотация

Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.

PJKD

Загрузки

Опубликован

2021-02-05

Выпуск

Том 3 № 10 (2019): Pakistan Journal of Kidney Diseases

Раздел

Review Article

Лицензия

Copyright (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema

Лицензия Creative Commons

Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial» («Атрибуция — Некоммерческое использование») 4.0 Всемирная.

Как цитировать

Phosphate Binders in CKD: ‟New Kids on the Block”. (2021). Pakistan Journal of Kidney Diseases, 3(10). https://doi.org/10.53778/pjkd31089